10 April 2026
10 April 2026
Through the integration, neurosurgeons gain a “plug-and-play” real-time visualisation tool using bkActiv and Stealth AXiS.
The trial will enrol up to 30 PAH and ten ILD-PH class II and III patients for ROC-101 combination therapy.
Gan & Lee will receive a $5m upfront payment plus up to $76.1m in milestone payments.
AI Airlock is jointly run by the MHRA, DHSC, NHS AI Team, and Team AB, the consortium of UK Approved Bodies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
